West Declares Quarterly Dividend
Rhea-AI Summary
West (NYSE: WST) declared a regular quarterly dividend of $0.22 per share on its common stock.
The board declared the dividend on December 9, 2025; it is payable on February 4, 2026 to shareholders of record on January 28, 2026.
Positive
- Quarterly dividend of $0.22 per share declared
Negative
- None.
News Market Reaction
On the day this news was published, WST gained 0.33%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
Peers showed mixed moves, from -0.16% (HOLX) to +2.83% (BAX), indicating no clear sector-wide driver aligned with this dividend announcement.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Oct 27 | Product launch | Positive | -3.5% | Launch of West Synchrony prefillable syringe system for biologics and vaccines. |
| Oct 24 | Investor conferences | Neutral | -3.2% | Announcement of multiple November–December 2025 investor conference appearances. |
| Oct 23 | Earnings results | Positive | +10.9% | Q3 2025 beat with higher net sales, EPS, and raised full-year guidance. |
| Oct 09 | Earnings call notice | Neutral | -1.6% | Scheduling of Q3 2025 results release and conference call details. |
| Aug 21 | Investor conferences | Neutral | -1.5% | Planned participation in three major September 2025 healthcare conferences. |
Earnings news saw a strong positive reaction, while product and conference updates often coincided with modest declines, suggesting selective enthusiasm for fundamental results.
Over recent months, West reported stronger Q3 2025 results with higher net sales and EPS, which coincided with a +10.92% move, contrasting with declines after product and conference announcements (e.g., -3.45% and -3.18%). The company has remained active with investor outreach and product launches in injectable drug administration. Today’s regular quarterly dividend fits into this pattern of ongoing shareholder returns alongside operational and financial updates.
Market Pulse Summary
This announcement details a regular quarterly dividend of $0.22 per share, payable on February 4, 2026 to shareholders of record on January 28, 2026. It continues West’s pattern of ongoing cash returns, following prior 2025 dividends of $0.21 per share. In context of recent earnings strength and active investor engagement, investors may watch for consistency in future dividends, overall cash generation, and capital allocation between dividends, buybacks, and growth initiatives.
AI-generated analysis. Not financial advice.
About West
West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With over 10,000 team members across 50 sites including 25 manufacturing facilities worldwide, West helps support our customers by delivering over 41 billion components and devices each year.
Headquartered in
All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries, in the United States and other jurisdictions, unless otherwise noted.
View original content to download multimedia:https://www.prnewswire.com/news-releases/west-declares-quarterly-dividend-302637318.html
SOURCE West Pharmaceutical Services, Inc.
FAQ
What dividend did West (WST) declare on December 9, 2025?
When is the West (WST) dividend payable and what is the record date?
Which shareholders of West (WST) are eligible for the February 4, 2026 dividend?
How often does West (WST) pay dividends?
Where can I find the payment and record dates for West (WST) dividends?
